Neurocrine Biosciences NBIX
NASDAQ NBIX
$174.41 +5.27 (+3.12%)
At close: Nov 11, 2026 · 4:00 PM EST

Neurocrine Biosciences (NBIX) Gains from Sales and Divestitures (2009 - 2026)

Updated

Analysis

Neurocrine Biosciences (NBIX) Gains from Sales and Divestitures (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Neurocrine Biosciences 17.13 Bn 13.21 Bn 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 28.60 Mn
Jun 30, 2018 147,000.00
Mar 31, 2018 201,000.00
Dec 31, 2017 156,000.00
Sep 30, 2017 188,000.00
Jun 30, 2017 881,000.00
Mar 31, 2017 879,000.00
Dec 31, 2016 863,000.00
Sep 30, 2016 844,000.00
Jun 30, 2016 868,000.00
Mar 31, 2016 856,000.00
Dec 31, 2015 838,000.00
Sep 30, 2015 828,000.00
Jun 30, 2015 829,000.00
Mar 31, 2015 839,000.00
Dec 31, 2014 812,000.00
Sep 30, 2014 806,000.00
Jun 30, 2014 810,000.00
Mar 31, 2014 794,000.00
Dec 31, 2013 788,000.00
API Access

Neurocrine Biosciences Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NBIX&period=max&api_key=YOUR_API_KEY